Penfluridol
An antipsychotic medication
Penfluridol | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Penfluridol is a long-acting antipsychotic medication primarily used in the treatment of schizophrenia and other chronic psychotic disorders. It belongs to the class of diphenylbutylpiperidine derivatives and is known for its prolonged duration of action, allowing for once-weekly dosing.
Pharmacology
Penfluridol acts as a dopamine receptor antagonist, particularly targeting the D2 receptors in the brain. This action helps to alleviate symptoms of psychosis, such as hallucinations and delusions. The drug's long half-life contributes to its extended duration of effect, making it suitable for patients who may have difficulty adhering to daily medication regimens.
Clinical Use
Penfluridol is indicated for the management of chronic psychotic disorders, including schizophrenia. Its once-weekly administration is advantageous in improving medication adherence in patients who struggle with daily dosing schedules. The medication is typically administered orally.
Side Effects
Common side effects of penfluridol include extrapyramidal symptoms, such as tremors, rigidity, and bradykinesia. Other potential side effects include sedation, weight gain, and anticholinergic effects like dry mouth and constipation. Long-term use may lead to tardive dyskinesia, a condition characterized by involuntary, repetitive body movements.
History
Penfluridol was developed in the 1960s and introduced into clinical practice in the 1970s. It was one of the first long-acting oral antipsychotics, providing an alternative to injectable depot antipsychotics. Despite its benefits, the use of penfluridol has declined with the advent of newer atypical antipsychotics that offer improved side effect profiles.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD